Shorter radiation after lumpectomy for early breast cancer
Part of Cancer, Skin clinical trials.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 50 or older.
- You must have early-stage breast cancer (noninvasive or invasive) that has not spread to other parts of the body.
- You must have had a lumpectomy (breast-conserving surgery), with or without a sentinel node biopsy.
- You cannot have had radiation to the same breast or chest area before.
- You cannot have certain autoimmune or connective tissue diseases like lupus or scleroderma.
- You must not be having a breast reduction procedure that moves tissue in the area where the tumor was removed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a very short, high-dose radiation treatment given directly to the breast after lumpectomy. It aims to make radiation more convenient by finishing in just a few days instead of weeks, possibly with fewer side effects.
This study compares a shorter course of radiation to a standard longer course after breast-conserving surgery (lumpectomy). It’s meant to see which schedule works just as well while focusing on safety and cancer control.
This trial tests whether a shorter course of radiation therapy (called hypofractionated) after lumpectomy is safe and works well for early breast cancer. It aims to make treatment more convenient while keeping the same benefits.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This study tests giving a shorter course of radiation to the whole breast after chemotherapy for early breast cancer. It aims to make treatment more convenient and may be an option for people who have had breast-conserving surgery.
This trial tests a shorter course of radiation therapy (called extreme hypofractionation) after surgery for early-stage breast cancer. It aims to see if fewer, higher-dose radiation sessions are as effective and safe as standard radiation, potentially reducing treatment time.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.